financetom
Business
financetom
/
Business
/
Brady's Fiscal Q2 Adjusted Earnings, Revenue Rise; Updates Annual Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brady's Fiscal Q2 Adjusted Earnings, Revenue Rise; Updates Annual Guidance
Feb 21, 2025 4:49 AM

07:20 AM EST, 02/21/2025 (MT Newswires) -- Brady (BRC) reported fiscal Q2 adjusted earnings Friday of $1, up from $0.93 a year earlier.

Two analysts polled by FactSet expected $1.03.

Revenue for the quarter ended Jan. 31 was $356.7 million compared with $322.6 million a year earlier.

Two analysts surveyed by FactSet expected $359.2 million.

The company raised the low end of its fiscal 2025 adjusted diluted EPS guidance to $4.45 to $4.70 from $4.40 to $4.70. Analysts surveyed by FactSet expect $4.62.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Celsius Likely Faces Sales Drop by End of Q3 Amid Pepsi Inventory Timing Issues, BofA Says
Celsius Likely Faces Sales Drop by End of Q3 Amid Pepsi Inventory Timing Issues, BofA Says
Sep 5, 2024
11:39 AM EDT, 09/05/2024 (MT Newswires) -- Celsius Holdings' ( CELH ) year-over-year sales are likely to decrease by the end of Q3 due to inventory timing issues with PepsiCo ( PEP ) , BofA Securities said in a note Thursday. Celsius Holdings ( CELH ) management announced [$100 million to $120 million] of expected inventory drag impacting [Q3], again...
Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Sep 5, 2024
(Adds background throughout) Sept 5 (Reuters) - U.S. drugmaker Eli Lilly ( LLY ) has signed a research deal with privately held AI-focused firm Genetic Leap to develop genetic medicines, the latter said on Thursday. WHY IT'S IMPORTANT Major drugmakers have been experimenting with artificial intelligence to discover new drugs, find patients for clinical trials and reduce the number of...
Argentina Lithium Exercises Options to Acquire Lithium-Prospective Properties
Argentina Lithium Exercises Options to Acquire Lithium-Prospective Properties
Sep 5, 2024
10:31 AM EDT, 09/05/2024 (MT Newswires) -- Argentina Lithium & Energy ( LILIF ) was at last look unchanged and trading near 52 week lows after saying Thursday that it has fully exercised its options to acquire 22 lithium-prospective properties totaling 25,391 hectares at its Rincon West, Pocitos and Antofalla North projects. The properties are subject to production royalties and...
C3.ai Delivers Good Fiscal Q1 With 'Some Spots of Weakness,' Wedbush Says
C3.ai Delivers Good Fiscal Q1 With 'Some Spots of Weakness,' Wedbush Says
Sep 5, 2024
11:22 AM EDT, 09/05/2024 (MT Newswires) -- C3.ai ( AI ) delivered good fiscal Q1 results and reaffirmed its fiscal 2025 revenue guidance, though there were some spots of weakness, Wedbush Securities said Thursday. Late Wednesday, the company reported fiscal Q1 financial results that surpassed Wall Street's estimates. C3.ai ( AI ) reaffirmed its fiscal 2025 revenue guidance of $370...
Copyright 2023-2026 - www.financetom.com All Rights Reserved